- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01995409
Mothers Learning About Second-hand Smoke - MLASS Study
Exposure to second-hand smoke during pregnancy and early infancy leads to low birth weight and childhood illnesses. 50% of all newborns in the UK are exposed to tobacco smoke due to maternal smoking or contact with second-hand smoke.
The purpose of this study is to test the feasibility of delivering and evaluating the effectiveness of a Smoke Free Homes (SFH) health education intervention with pregnant women and mothers with newborns to reduce unborn and newborn babies exposure to second-hand smoke. The intervention will be delivered through routine antenatal and postnatal healthcare settings provided by midwifery and health visiting services.
The intervention consists of educational materials to be given to the woman and a conversation held between the woman and midwife/health visitor about protecting the baby from second-hand smoke. The development of the intervention has been informed by the views of health professionals and service users, incorporates behaviour change theory and has drawn on other SFH materials developed for other settings. Different parts of the intervention will be delivered at different points along the antenatal and postnatal care pathway. 200 pregnant women and their newborns will be recruited.
We will measure salivary cotinine levels to assess the level of exposure to SHS in women and urinary cotinine levels in newborns. We plan to conduct a before-and-after study of the delivery of the intervention to test the feasibility of delivering, and methods to evaluate the effectiveness of the intervention.
Feasibility study outputs:
- A standardised, acceptable, feasible and appropriate health education intervention to protect unborn and newborn babies exposure to second-hand smoke at home, capable of being integrated into routine midwifery and health visiting practice
- A trial protocol to evaluate the effectiveness of the intervention on unborn and newborn babies' exposure to secondhand smoke.
Study Overview
Status
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Julie Scarfe, RN, RM, BSc, MA.
- Phone Number: 0113 2066975
- Email: Julie.Scarfe@leedsth.nhs.uk
Study Locations
-
-
-
Leeds, United Kingdom, LS9 7TF
- Recruiting
- The Leeds Teaching Hospital NHS Trust
-
Contact:
- Julie Scarfe, RN, RM, BSc, MA.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion criteria for women
- Pregnant
- Smokers; or, non-smokers who live in a household with an adult who smokes or in a household with regular visitors to the home who smoke
- Aged 17-40 years of age
- Living in neighbourhoods in Leeds that are among the 40% most deprived in England Inclusion criteria for newborns
- Born to a woman already recruited into the study
Exclusion Criteria:
Exclusion criteria for women
- Not pregnant or have a miscarriage during pregnancy
- Non-smokers who do not live in a household with an adult who smokes or in a household with regular visitors to the home who smoke
- Having serious health complications during pregnancy or after childbirth
- Known or suspected to be in an abusive relationship Exclusion criteria for newborns
- Having serious health complications after birth or requiring hospitalisation
- Living in neighbourhoods in Leeds that are not among the 40% most deprived in England . being permanently looked after in home separate from mother's
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Salivary cotinine levels in women who do not smoke during pregnancy, and urine cotinine levels in newborns.
Time Frame: 1 year
|
We will assess the level of smoking restrictions at home through a Household Survey (questionnaire) completed by the women. The survey is divided into two parts. Part One asks for demographic information and this information will only be collected once, at the start of the study. Part Two asks about smoking behaviour and is based on two questions; (a) Do people in the house smoke in front of pregnant mothers and children? (b) Where do people smoke? Participants will be asked to complete Part B at different points throughout their involvement in the study so that the impact of the delivery of different stages of the intervention can be assessed. Responses to question (a) will be assessed as a binary outcome. However, responses to question (b) will be grouped into one of three categories. Smoking takes place; (i) in any part of the house; (ii) in one room only; (iii) only outside the house. We will add an additional question to assess smoking restrictions on the visitors. |
1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- OG13/10649
- 12/YH/0257 (Other Identifier: Research Ethics Committee)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on The Effects of Second-hand Smoke in New Borns
-
Oregon Health and Science UniversityNational Heart, Lung, and Blood Institute (NHLBI); Office of Dietary Supplements...CompletedSecond Hand Smoke | Pulmonary Function; Newborn, Abnormal | Infant Wheeze | In-utero NicotineUnited States
-
Merz North America, Inc.CompletedVolume Loss in the Dorsum of the HandUnited States
-
Merz North America, Inc.CompletedVolume Loss in the Dorsum of the HandUnited States
-
Active Life Scientific, Inc.MCRACompletedAdverse Effects in the Use of the OsteoProbe SystemUnited States
-
Weill Medical College of Cornell UniversityCompletedAmbulatory Care Patients Who Were Hospitalized in 2001 at the Cornell Campus of the New York-Presbyterian HospitalUnited States
-
Kasr El Aini HospitalUnknownEffect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes (RCT)The Length of Second Labor Stage in Primigravidae on Maternal & Neonatal Outcomes
-
Maco Productions S.A.S.SynteractHCRCompletedAdverse Effects in the Therapeutic Use of Plasma SubstitutesUnited Kingdom, Belgium, Greece, Spain
-
Saint-Joseph UniversityRecruitingShivering | Adverse Effects in the Therapeutic Use of AnaestheticLebanon
-
OctapharmaCompletedAdverse Effects in the Therapeutic Use of Plasma SubstitutesUnited States
-
Heba A YassaEnrolling by invitationthe Study Focus on the Uses of Telephone and Other New Technology in Medicine, Diagnosis and TreatmentEgypt
Clinical Trials on No smoking material provided in households with newborn infants
-
Virginia Commonwealth UniversityRecruiting